United Kingdom Researchers Integrate C2N’s PrecivityAD2® Blood Test Into the Alzheimer’s Disease Diagnostic Care Pathway
ST. LOUIS, July 29, 2026–(BUSINESS WIRE)–Researchers in the United Kingdom are using the PrecivityAD2® blood test from C2N…